NCT05275179View on ClinicalTrials.gov

Pharmacokinetic of Posaconazole in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

November 1, 2022

Conditions
Therapeutic Drug MonitoringCritical Illness
Interventions
OTHER

Posaconazole Therapeutic Drug Monitoring

Therapeutic Drug Monitoring is performed by measuring posaconazole concentrations in serum on seven consecutive days (anticipated).

Trial Locations (1)

20246

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT05275179 - Pharmacokinetic of Posaconazole in Critically Ill Patients | Biotech Hunter | Biotech Hunter